Skip to main content
. 2019 May 2;21(5):e11855. doi: 10.2196/11855

Table 1.

Predictors of online response: frequency and percentage of online response by patient characteristic and cancer site variables and related crude and adjusted odds ratios of online response (N=63,134).

Variable Frequency and percentage of online response Univariable logistic regression models Multivariable logistic regression model

n (%) Total, N ORa (95% CI) P valueb aORc (95% CI) P valueb
Sex


<.001
<.001

Male 2543 (8.78) 28,973 1
1

Female 2092 (6.12) 34,161 0.68 (0.64-0.72)
0.50 (0.46-0.54)
Age group (years)


<.001
<.001

<55 1457 (15.28) 9535 2.82 (2.61-3.05)
3.49 (3.21-3.80)

55-64 1377 (10.66) 12,913 1.87 (1.72-2.02)
2.05 (1.89-2.22)

65-74 1347 (6.01) 22,395 1
1

≥75 454 (2.48) 18,291 0.40 (0.36-0.44)
0.39 (0.35-0.43)
IMD score


<.001
<.001

Quintile 1 (least deprived) 1231 (8.06) 15,264 1
1

Quintile 2 1163 (7.84) 14,832 0.97 (0.89-1.05)
0.96 (0.88-1.04)

Quintile 3 1016 (7.33) 13,853 0.90 (0.83-0.98)
0.85 (0.78-0.93)

Quintile 4 749 (6.83) 10,963 0.84 (0.76-0.92)
0.75 (0.68-0.83)

Quintile 5 (most deprived) 476 (5.79) 8222 0.70 (0.63-0.78)
0.57 (0.51-0.64)
Ethnic group


<.001
<.001

White 4083 (7.03) 58,067 1
1

Nonwhite 552 (10.89) 5067 1.62 (1.47-1.78)
1.37 (1.24-1.51)
Cancer sited


<.001
.01

Prostate 527 (9.21) 5725 1.23 (1.05-1.44)
1.19 (1.01-1.41)

Leukemia 220 (9.27) 2373 1.24 (1.02-1.50)
1.15 (0.95-1.41)

Endometrial 78 (5.55) 1406 0.71 (0.55-0.93)
1.11 (0.84-1.46)

Non-Hodgkin lymphoma 350 (7.88) 4444 1.04 (0.87-1.23)
1.10 (0.92-1.31)

Colon 308 (6.80) 4530 0.89 (0.74-1.06)
1.03 (0.86-1.24)

Other cancers 1265 (7.76) 16,292 1.02 (0.88-1.18)
1.01 (0.87-1.18)

Rectal 235 (7.61) 3087 1
1

Breast 949 (7.35) 12,904 0.96 (0.83-1.12)
1.00 (0.85-1.18)

Multiple myeloma 298 (6.54) 4555 0.85 (0.71-1.02)
0.99 (0.83-1.19)

Bladder 239 (5.39) 4437 0.69 (0.57-0.83)
0.96 (0.80-1.17)

Lung 166 (4.91) 3381 0.63 (0.51-0.77)
0.83 (0.67-1.02)

Total 4635 (7.34) 63,134



aUnadjusted odds ratios (ORs) of online response from a series of univariable logistic regression models, conditional on each patient characteristic and cancer site variable considered.

bP values from joint Wald tests.

cAdjusted odds ratios (aORs) of online response from a multivariable logistic regression model, conditional on all patient characteristic and cancer site variables considered.

dResponders with renal and thyroid cancers (grouped into the “other” category) and melanoma skin cancer excluded due to their ethnic group being suppressed or missing.